316
Participants
Start Date
November 14, 2023
Primary Completion Date
July 27, 2027
Study Completion Date
July 27, 2027
Dostarlimab
Dostarlimab will be administered.
Belrestotug
Belrestotug will be administered.
Nelistotug
Nelistotug will be administered.
Remzistotug
Remzistotug will be administered.
GSK Investigational Site, Changhua
GSK Investigational Site, Tainan City
GSK Investigational Site, Santa Fe
GSK Investigational Site, Nyíregyháza
GSK Investigational Site, Córdoba
GSK Investigational Site, San Juan
GSK Investigational Site, Kecskemét
GSK Investigational Site, Pécs
GSK Investigational Site, Győr
GSK Investigational Site, Taipei
GSK Investigational Site, Taipei
GSK Investigational Site, Berlin
GSK Investigational Site, Haidari - Athens
GSK Investigational Site, Marseille
GSK Investigational Site, Seongnam-si Gyeonggi-do
GSK Investigational Site, Caen
GSK Investigational Site, Genova
GSK Investigational Site, Rozzano MI
GSK Investigational Site, Milan
GSK Investigational Site, Hamburg
GSK Investigational Site, Turku
GSK Investigational Site, Jaén
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Novara
GSK Investigational Site, Pozuelo de AlarcOn Madr
GSK Investigational Site, Bucharest
GSK Investigational Site, Bordeaux
GSK Investigational Site, Istanbul
GSK Investigational Site, Izmir
GSK Investigational Site, Padua
GSK Investigational Site, Giessen
GSK Investigational Site, Salamanca
GSK Investigational Site, Santander
GSK Investigational Site, Bologna
GSK Investigational Site, Daegu
GSK Investigational Site, Columbus
GSK Investigational Site, Essen
GSK Investigational Site, Valencia
GSK Investigational Site, Zaragoza
GSK Investigational Site, Florence
GSK Investigational Site, Aachen
GSK Investigational Site, Iowa City
GSK Investigational Site, Milwaukee
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Frankfurt
GSK Investigational Site, St Louis
GSK Investigational Site, Bari
GSK Investigational Site, Paris
GSK Investigational Site, Rouen
GSK Investigational Site, Napoli
GSK Investigational Site, Ulm
GSK Investigational Site, Regensburg
GSK Investigational Site, Villejuif
GSK Investigational Site, Piteşti
GSK Investigational Site, Craiova
GSK Investigational Site, Craiova
GSK Investigational Site, Floreşti
GSK Investigational Site, Oradea
GSK Investigational Site, Brasov
GSK Investigational Site, Iași
GSK Investigational Site, Suceava
GSK Investigational Site, New Haven
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Capital Federal
GSK Investigational Site, Ciudad Autonoma de Bueno
GSK Investigational Site, Florida
GSK Investigational Site, Mendoza
GSK Investigational Site, Santo André
GSK Investigational Site, São Paulo
GSK Investigational Site, São Paulo
GSK Investigational Site, Calgary
GSK Investigational Site, Edmonton
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Herlev
GSK Investigational Site, Marousi
GSK Investigational Site, Leipzig
GSK Investigational Site, Roma
GSK Investigational Site, Roma
GSK Investigational Site, Aichi
GSK Investigational Site, Chiba
GSK Investigational Site, Hyōgo
GSK Investigational Site, Osaka
GSK Investigational Site, Saitama
GSK Investigational Site, Shizuoka
GSK Investigational Site, Tokyo
GSK Investigational Site, Oslo
GSK Investigational Site, Bielsko-Biala
GSK Investigational Site, Gliwice
GSK Investigational Site, Katowice
GSK Investigational Site, Krakow
GSK Investigational Site, Przemyśl
GSK Investigational Site, Siedlce
GSK Investigational Site, Warsaw
GSK Investigational Site, Almada
GSK Investigational Site, Lisbon
GSK Investigational Site, Porto
GSK Investigational Site, Porto
GSK Investigational Site, Bucharest
GSK Investigational Site, Bucharest
GSK Investigational Site, Bucharest
GSK Investigational Site, Bucharest
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Suwon Kyunggi-do
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Ankara
Lead Sponsor
Collaborators (1)
iTeos Therapeutics
INDUSTRY
GlaxoSmithKline
INDUSTRY